Legend Biotech has announced the pricing of its public offering, raising $226 million by setting the share price at $29.35. This offering is expected to enhance the company's financial position and support its ongoing projects in the biotechnology sector. The shares will be made available to investors in the coming days, with the proceeds aimed at funding research and development initiatives.
Related Articles
Don't miss out on breaking stories and in-depth articles.